Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biological Science Disciplines | 3 | 2023 | 57 | 2.350 |
Why?
|
HIV Infections | 31 | 2023 | 17352 | 1.440 |
Why?
|
Aging | 15 | 2024 | 8711 | 1.280 |
Why?
|
HIV-1 | 21 | 2022 | 6863 | 0.930 |
Why?
|
Journal Impact Factor | 1 | 2023 | 153 | 0.760 |
Why?
|
Geriatrics | 2 | 2023 | 388 | 0.760 |
Why?
|
Plants | 1 | 2022 | 327 | 0.740 |
Why?
|
RNA Editing | 3 | 2010 | 151 | 0.710 |
Why?
|
Air Pollutants, Occupational | 1 | 2022 | 407 | 0.690 |
Why?
|
Muscle, Skeletal | 9 | 2023 | 4948 | 0.670 |
Why?
|
Sarcopenia | 2 | 2023 | 372 | 0.660 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.610 |
Why?
|
Testosterone | 8 | 2022 | 2472 | 0.590 |
Why?
|
Longevity | 6 | 2023 | 1065 | 0.580 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 131 | 0.570 |
Why?
|
Neurosciences | 1 | 2022 | 367 | 0.570 |
Why?
|
Inflammation | 6 | 2023 | 10773 | 0.550 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2022 | 1897 | 0.540 |
Why?
|
Publishing | 1 | 2023 | 833 | 0.510 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 831 | 0.500 |
Why?
|
Continuity of Patient Care | 1 | 2022 | 1069 | 0.470 |
Why?
|
Neisseria gonorrhoeae | 2 | 2006 | 239 | 0.430 |
Why?
|
Antigens, Ly | 2 | 2010 | 295 | 0.420 |
Why?
|
Occupational Exposure | 1 | 2022 | 1813 | 0.400 |
Why?
|
Osteoporosis | 1 | 2022 | 1606 | 0.400 |
Why?
|
Gonorrhea | 2 | 2006 | 346 | 0.390 |
Why?
|
Hepatitis C | 1 | 2022 | 1584 | 0.380 |
Why?
|
Mitochondria | 1 | 2024 | 3624 | 0.370 |
Why?
|
Circadian Rhythm | 1 | 2022 | 2576 | 0.360 |
Why?
|
Virus Activation | 1 | 2012 | 322 | 0.350 |
Why?
|
Azepines | 1 | 2012 | 329 | 0.350 |
Why?
|
Biology | 2 | 2022 | 290 | 0.340 |
Why?
|
Fractures, Bone | 1 | 2022 | 2046 | 0.330 |
Why?
|
Virus Latency | 1 | 2012 | 363 | 0.330 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 1844 | 0.330 |
Why?
|
Physical Fitness | 1 | 2013 | 743 | 0.320 |
Why?
|
Androgens | 3 | 2017 | 1286 | 0.320 |
Why?
|
Myoblasts | 1 | 2010 | 231 | 0.320 |
Why?
|
Adenosine Deaminase | 2 | 2010 | 251 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3245 | 0.310 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2895 | 0.310 |
Why?
|
Anti-HIV Agents | 4 | 2022 | 4527 | 0.300 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2006 | 1351 | 0.300 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.290 |
Why?
|
HIV Long Terminal Repeat | 6 | 2002 | 85 | 0.290 |
Why?
|
Exercise | 4 | 2020 | 5890 | 0.290 |
Why?
|
NF-kappa B | 6 | 2002 | 2490 | 0.290 |
Why?
|
HIV Wasting Syndrome | 1 | 2007 | 99 | 0.280 |
Why?
|
Triazoles | 1 | 2012 | 903 | 0.280 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1334 | 0.270 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 733 | 0.270 |
Why?
|
Osteoblasts | 1 | 2012 | 1143 | 0.270 |
Why?
|
Proviruses | 4 | 2013 | 313 | 0.260 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 934 | 0.260 |
Why?
|
Energy Metabolism | 4 | 2022 | 2882 | 0.260 |
Why?
|
Regeneration | 2 | 2010 | 1512 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2013 | 4352 | 0.240 |
Why?
|
Humans | 61 | 2024 | 761572 | 0.240 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5440 | 0.230 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1784 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.220 |
Why?
|
Interleukin-6 | 1 | 2013 | 3208 | 0.220 |
Why?
|
HIV | 4 | 2023 | 1582 | 0.210 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.210 |
Why?
|
Enhancer Elements, Genetic | 2 | 2000 | 1363 | 0.200 |
Why?
|
Viral Load | 6 | 2006 | 3332 | 0.200 |
Why?
|
Viral Tropism | 2 | 2013 | 102 | 0.190 |
Why?
|
RNA Interference | 1 | 2010 | 2832 | 0.190 |
Why?
|
Th1 Cells | 1 | 2006 | 1036 | 0.180 |
Why?
|
Protein Modification, Translational | 1 | 2020 | 21 | 0.180 |
Why?
|
Terminal Repeat Sequences | 2 | 2000 | 70 | 0.180 |
Why?
|
Th2 Cells | 1 | 2006 | 1060 | 0.180 |
Why?
|
Disease Management | 2 | 2022 | 2508 | 0.170 |
Why?
|
TATA Box | 2 | 2001 | 127 | 0.170 |
Why?
|
Botswana | 6 | 2007 | 1048 | 0.170 |
Why?
|
Genes, Helminth | 2 | 2010 | 147 | 0.170 |
Why?
|
Immunity, Innate | 2 | 2010 | 3066 | 0.160 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4176 | 0.160 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2012 | 439 | 0.160 |
Why?
|
RNA, Messenger | 2 | 2012 | 12794 | 0.150 |
Why?
|
Neoplasms | 2 | 2022 | 22173 | 0.150 |
Why?
|
Membrane Proteins | 3 | 2010 | 7858 | 0.150 |
Why?
|
Viremia | 4 | 2018 | 707 | 0.150 |
Why?
|
Aged | 15 | 2023 | 169310 | 0.150 |
Why?
|
MicroRNAs | 2 | 2011 | 3816 | 0.150 |
Why?
|
NAD | 1 | 2022 | 614 | 0.150 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2024 | 803 | 0.150 |
Why?
|
Congresses as Topic | 2 | 2019 | 803 | 0.150 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2012 | 629 | 0.150 |
Why?
|
Middle Aged | 19 | 2023 | 220920 | 0.140 |
Why?
|
Body Composition | 3 | 2020 | 2426 | 0.140 |
Why?
|
Mental Fatigue | 1 | 2017 | 23 | 0.140 |
Why?
|
Cell Line | 6 | 2012 | 15601 | 0.140 |
Why?
|
Muscle Proteins | 1 | 2022 | 1154 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2008 | 9420 | 0.140 |
Why?
|
Proteome | 2 | 2022 | 1862 | 0.140 |
Why?
|
Iron-Binding Proteins | 1 | 2016 | 79 | 0.140 |
Why?
|
Comorbidity | 4 | 2022 | 10508 | 0.130 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
Gene Products, tat | 3 | 2002 | 111 | 0.130 |
Why?
|
Cohort Studies | 6 | 2023 | 41493 | 0.130 |
Why?
|
Male | 27 | 2023 | 360842 | 0.130 |
Why?
|
Blood Cell Count | 1 | 2016 | 397 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2008 | 3778 | 0.120 |
Why?
|
Erythrocyte Deformability | 1 | 2015 | 55 | 0.120 |
Why?
|
Cytokines | 2 | 2010 | 7396 | 0.120 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10194 | 0.120 |
Why?
|
Blood Viscosity | 1 | 2015 | 124 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2019 | 4369 | 0.120 |
Why?
|
Muscles | 1 | 2019 | 1576 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2020 | 1079 | 0.110 |
Why?
|
Frail Elderly | 1 | 2019 | 765 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11904 | 0.110 |
Why?
|
CD4 Lymphocyte Count | 5 | 2013 | 2571 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2012 | 2707 | 0.110 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3801 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 535 | 0.110 |
Why?
|
Life Expectancy | 2 | 2019 | 1242 | 0.110 |
Why?
|
Receptors, HIV | 1 | 2013 | 159 | 0.110 |
Why?
|
Promoter Regions, Genetic | 3 | 2000 | 5790 | 0.110 |
Why?
|
Bone Resorption | 1 | 2017 | 723 | 0.110 |
Why?
|
Monocyte-Macrophage Precursor Cells | 1 | 2012 | 5 | 0.110 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 541 | 0.100 |
Why?
|
Female | 27 | 2023 | 392686 | 0.100 |
Why?
|
Cross-Sectional Studies | 6 | 2019 | 26127 | 0.100 |
Why?
|
Smad7 Protein | 1 | 2012 | 39 | 0.100 |
Why?
|
DNA, Viral | 5 | 2013 | 2202 | 0.100 |
Why?
|
Bayes Theorem | 3 | 2016 | 2330 | 0.100 |
Why?
|
Biopsy | 2 | 2018 | 6766 | 0.100 |
Why?
|
Transcription, Genetic | 5 | 2012 | 7593 | 0.100 |
Why?
|
Simian immunodeficiency virus | 1 | 2017 | 809 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 158 | 0.100 |
Why?
|
Survivors | 1 | 2022 | 2371 | 0.090 |
Why?
|
Fatigue | 1 | 2018 | 1552 | 0.090 |
Why?
|
Myoblasts, Skeletal | 1 | 2010 | 75 | 0.090 |
Why?
|
Caenorhabditis elegans | 2 | 2010 | 1456 | 0.090 |
Why?
|
Health Status | 1 | 2023 | 4077 | 0.090 |
Why?
|
Animals | 12 | 2024 | 168467 | 0.090 |
Why?
|
3T3 Cells | 1 | 2012 | 1085 | 0.090 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2012 | 343 | 0.090 |
Why?
|
Enzyme Induction | 1 | 2010 | 452 | 0.080 |
Why?
|
eIF-2 Kinase | 1 | 2010 | 145 | 0.080 |
Why?
|
Cost of Illness | 1 | 2019 | 1936 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 2010 | 239 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 195 | 0.080 |
Why?
|
Transcription Factors | 4 | 2012 | 12129 | 0.080 |
Why?
|
Models, Biological | 3 | 2010 | 9469 | 0.080 |
Why?
|
Complement C3 | 1 | 2010 | 435 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2013 | 610 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2012 | 5485 | 0.080 |
Why?
|
Muscle Development | 1 | 2010 | 259 | 0.080 |
Why?
|
Immunoglobulin M | 2 | 2010 | 1526 | 0.080 |
Why?
|
Tacrolimus | 1 | 2012 | 733 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 581 | 0.080 |
Why?
|
Ligands | 2 | 2017 | 3272 | 0.070 |
Why?
|
Adult | 17 | 2023 | 221203 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1723 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 634 | 0.070 |
Why?
|
Drug Synergism | 1 | 2012 | 1756 | 0.070 |
Why?
|
Base Sequence | 8 | 2000 | 12441 | 0.070 |
Why?
|
Military Personnel | 1 | 2017 | 1246 | 0.070 |
Why?
|
RNA Stability | 1 | 2010 | 329 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1063 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6770 | 0.070 |
Why?
|
Signal Transduction | 5 | 2012 | 23447 | 0.070 |
Why?
|
Genome, Human | 2 | 2012 | 4425 | 0.070 |
Why?
|
Voluntary Programs | 1 | 2006 | 48 | 0.070 |
Why?
|
Chemokine CCL8 | 1 | 2006 | 17 | 0.070 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2006 | 47 | 0.070 |
Why?
|
Molecular Sequence Data | 8 | 2002 | 17635 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3810 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3415 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4580 | 0.060 |
Why?
|
Mothers | 2 | 2006 | 2198 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1612 | 0.060 |
Why?
|
Horse Diseases | 1 | 1995 | 55 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8633 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3341 | 0.060 |
Why?
|
AIDS Serodiagnosis | 1 | 2006 | 220 | 0.060 |
Why?
|
Binding Sites | 3 | 2000 | 6056 | 0.060 |
Why?
|
Phagocytosis | 1 | 2010 | 1528 | 0.060 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 2002 | 119 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3826 | 0.060 |
Why?
|
Multigene Family | 1 | 2008 | 1076 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6992 | 0.060 |
Why?
|
Diet | 2 | 2020 | 8075 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2010 | 1897 | 0.060 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1756 | 0.060 |
Why?
|
Postnatal Care | 1 | 2006 | 262 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5112 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1023 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2001 | 5799 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2012 | 11530 | 0.060 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2006 | 416 | 0.050 |
Why?
|
Virus Replication | 4 | 2004 | 2435 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3303 | 0.050 |
Why?
|
Milk, Human | 1 | 2007 | 486 | 0.050 |
Why?
|
Mice | 6 | 2015 | 81533 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 1997 | 9610 | 0.050 |
Why?
|
RNA, Viral | 4 | 2004 | 2846 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 589 | 0.050 |
Why?
|
Sequence Alignment | 4 | 2002 | 2180 | 0.050 |
Why?
|
Drug Resistance, Viral | 2 | 2004 | 862 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6391 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6597 | 0.050 |
Why?
|
Genotype | 4 | 2012 | 12990 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6214 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2456 | 0.050 |
Why?
|
Interleukins | 1 | 2006 | 782 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2002 | 740 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 1995 | 504 | 0.050 |
Why?
|
Phylogeny | 5 | 2000 | 2811 | 0.040 |
Why?
|
Boston | 1 | 2013 | 9326 | 0.040 |
Why?
|
Polyesters | 1 | 2022 | 373 | 0.040 |
Why?
|
Body Weight | 3 | 2019 | 4618 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1998 | 1058 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4575 | 0.040 |
Why?
|
Zimbabwe | 1 | 2000 | 135 | 0.040 |
Why?
|
Response Elements | 1 | 2001 | 309 | 0.040 |
Why?
|
Abdomen | 1 | 1995 | 1128 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 306 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8540 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 88324 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8321 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 225 | 0.040 |
Why?
|
Gene Frequency | 3 | 2012 | 3606 | 0.040 |
Why?
|
Counseling | 1 | 2006 | 1547 | 0.040 |
Why?
|
Vagina | 1 | 2003 | 838 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3162 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2023 | 58986 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2012 | 15936 | 0.040 |
Why?
|
Models, Genetic | 2 | 2012 | 3442 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 1997 | 254 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10448 | 0.030 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1996 | 103 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 869 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1996 | 100 | 0.030 |
Why?
|
Macrophages | 1 | 2010 | 5769 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2006 | 26198 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 1997 | 389 | 0.030 |
Why?
|
Weight Loss | 1 | 2007 | 2684 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2019 | 701 | 0.030 |
Why?
|
Appetite | 1 | 2017 | 247 | 0.030 |
Why?
|
Personality Assessment | 1 | 2017 | 650 | 0.030 |
Why?
|
Young Adult | 5 | 2023 | 59255 | 0.030 |
Why?
|
Odds Ratio | 2 | 2022 | 9646 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54426 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 818 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1999 | 1519 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3523 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7213 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2001 | 1067 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2009 | 1998 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1998 | 529 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15501 | 0.030 |
Why?
|
Orchiectomy | 1 | 2015 | 463 | 0.030 |
Why?
|
Rural Population | 1 | 2003 | 2285 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3205 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 2822 | 0.020 |
Why?
|
Menopause | 1 | 2019 | 1646 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4124 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2880 | 0.020 |
Why?
|
Research | 1 | 2019 | 1982 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2010 | 166 | 0.020 |
Why?
|
HeLa Cells | 1 | 1996 | 3094 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2329 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 18965 | 0.020 |
Why?
|
Virus Internalization | 1 | 2013 | 497 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20099 | 0.020 |
Why?
|
Gene Products, gag | 2 | 2001 | 312 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4920 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2009 | 277 | 0.020 |
Why?
|
Genetic Variation | 2 | 2001 | 6567 | 0.020 |
Why?
|
United States | 3 | 2022 | 72335 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12341 | 0.020 |
Why?
|
Campylobacter jejuni | 1 | 2007 | 24 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2001 | 3847 | 0.020 |
Why?
|
Infant | 2 | 2007 | 36192 | 0.020 |
Why?
|
Pregnancy | 3 | 2007 | 29876 | 0.020 |
Why?
|
Haemophilus influenzae | 1 | 2007 | 178 | 0.020 |
Why?
|
Maternal-Child Health Centers | 1 | 2006 | 42 | 0.020 |
Why?
|
HIV Seroprevalence | 1 | 2006 | 89 | 0.020 |
Why?
|
Bone Marrow | 1 | 2017 | 2911 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 80646 | 0.020 |
Why?
|
Family | 1 | 2017 | 3194 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2901 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2007 | 1060 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18398 | 0.020 |
Why?
|
Fetal Hemoglobin | 1 | 2008 | 345 | 0.020 |
Why?
|
Marital Status | 1 | 2006 | 426 | 0.020 |
Why?
|
Horses | 1 | 1995 | 300 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22172 | 0.010 |
Why?
|
DNA Primers | 2 | 1999 | 2819 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1996 | 4513 | 0.010 |
Why?
|
Occupations | 1 | 2006 | 515 | 0.010 |
Why?
|
HIV Protease | 1 | 2004 | 97 | 0.010 |
Why?
|
HIV Core Protein p24 | 1 | 2004 | 245 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4174 | 0.010 |
Why?
|
Helicobacter pylori | 1 | 2007 | 377 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2007 | 978 | 0.010 |
Why?
|
Bone Density | 1 | 2017 | 3551 | 0.010 |
Why?
|
Sutures | 1 | 1995 | 284 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 809 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1995 | 15633 | 0.010 |
Why?
|
HIV Enhancer | 1 | 2002 | 3 | 0.010 |
Why?
|
Models, Statistical | 2 | 2012 | 5079 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4740 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10721 | 0.010 |
Why?
|
Time Factors | 3 | 2015 | 39970 | 0.010 |
Why?
|
U937 Cells | 1 | 2002 | 261 | 0.010 |
Why?
|
Algorithms | 3 | 2009 | 14032 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2007 | 730 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 997 | 0.010 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 432 | 0.010 |
Why?
|
Cyclin T | 1 | 2001 | 19 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2601 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1469 | 0.010 |
Why?
|
Africa, Southern | 1 | 2001 | 59 | 0.010 |
Why?
|
Sleep | 1 | 2017 | 4768 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
Chemoreceptor Cells | 1 | 2001 | 89 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6864 | 0.010 |
Why?
|
Sex Distribution | 1 | 1995 | 2281 | 0.010 |
Why?
|
HIV-2 | 1 | 2001 | 156 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 6075 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 12954 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2426 | 0.010 |
Why?
|
Breast Feeding | 1 | 2007 | 1360 | 0.010 |
Why?
|
Educational Status | 1 | 2006 | 2522 | 0.010 |
Why?
|
Cyclins | 1 | 2001 | 594 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13446 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1403 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 365 | 0.010 |
Why?
|
Senegal | 1 | 1999 | 256 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13510 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1998 | 151 | 0.010 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2001 | 504 | 0.010 |
Why?
|
Gene Products, env | 1 | 1999 | 250 | 0.010 |
Why?
|
Ukraine | 1 | 1998 | 149 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6228 | 0.010 |
Why?
|
Treatment Failure | 1 | 2004 | 2644 | 0.010 |
Why?
|
Giant Cells | 1 | 1998 | 188 | 0.010 |
Why?
|
Genes, Viral | 1 | 1998 | 649 | 0.010 |
Why?
|
North America | 1 | 2001 | 1276 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2000 | 582 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 1998 | 469 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2000 | 755 | 0.010 |
Why?
|
Plasmids | 1 | 2001 | 2269 | 0.010 |
Why?
|
Computational Biology | 1 | 2008 | 3517 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4544 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2004 | 2571 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6241 | 0.010 |
Why?
|
Tanzania | 1 | 1999 | 1387 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2748 | 0.010 |
Why?
|
Europe | 1 | 2001 | 3422 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 1999 | 960 | 0.010 |
Why?
|
India | 1 | 2000 | 2348 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5774 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7827 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14666 | 0.010 |
Why?
|
Gene Deletion | 1 | 2000 | 2665 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13255 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2006 | 4016 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1699 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 64684 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2199 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17904 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 22176 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 14607 | 0.000 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1999 | 2151 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12725 | 0.000 |
Why?
|
Child, Preschool | 1 | 2007 | 42230 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74213 | 0.000 |
Why?
|
Phenotype | 1 | 1998 | 16592 | 0.000 |
Why?
|